• News Feeds
Page last updated at 08:00 GMT, Monday, 5 April 2010 09:00 UK

'Sleight of hand' over Tory cancer drugs pledge

Advertisement

Professor John Appleby, chief economist of the think tank the King's Fund, has said that Conservative proposals to make a wider range of cancer drugs available to patients were flawed and could amount to a "sleight of hand, to say the least".

He told Today presenter John Humphrys that the pledge, which could cost up to £200m a year, was "like making a saving on a tax that hasn't been implemented yet".

And he added that the funding would have to come out of existing budgets.

But the shadow health secretary Andrew Lansley strongly defended the policy. He said that it would be funded by making available money which would be paid by the NHS in increased employers' National Insurance contributions due to be introduced next April, a sum which he estimated at around £200m a year.

Mr Lansley added that there was a "major problem" with cancer drugs in the UK, which he says sees a far lower uptake among patients than other countries. And he called for the government and pharmaceutical companies to collaborate on a different system of pricing for drugs.

Get in touch on email , Twitter or Facebook

SEE ALSO

Story Tools

BBC navigation

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific